Skip to main content
Funding round pulls in $35.5M for Amphora Medical

A round of Series B financing led by Boston Scientific and Longitude Capital brought in $35.5 million for Maple Grove, Minn.-based Amphora Medical. The proceeds will be used for a US pivotal study to evaluate use of the company's Selective Bladder Denervation System in treating women with overactive bladder.

Full Story: